First Bancorp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$332K Sell
287
-3
-1% -$3.54K 0.14% 102
2026
Q2
$348K Sell
290
-26
-8% -$26.6K 0.14% 101
2026
Q1
$291K Sell
316
-5
-2% -$5.07K 0.14% 109
2025
Q4
$345K Sell
321
-77
-19% -$73.6K 0.18% 99
2025
Q3
$304K Sell
398
-44
-10% -$32.7K 0.16% 108
2025
Q2
$345K Sell
442
-50
-10% -$38.9K 0.2% 96
2025
Q1
$406K Sell
492
-17
-3% -$14.1K 0.26% 85
2024
Q4
$393K Sell
509
-4
-0.8% -$3.31K 0.27% 82
2024
Q3
$454K Sell
513
-8
-2% -$7.19K 0.32% 73
2024
Q2
$472K Sell
521
-85
-14% -$68K 0.35% 64
2024
Q1
$471K Sell
606
-104
-15% -$74K 0.36% 67
2023
Q4
$414K Sell
710
-30
-4% -$17.5K 0.33% 68
2023
Q3
$397K Sell
740
-46
-6% -$23.7K 0.35% 63
2023
Q2
$369K Sell
786
-23
-3% -$9.6K 0.3% 73
2023
Q1
$278K Hold
809
– – 0.24% 87
2022
Q4
$296K Sell
809
-40
-5% -$14.2K 0.25% 80
2022
Q3
$274K Sell
849
-64
-7% -$20.3K 0.25% 82
2022
Q2
$296K Sell
913
-89
-9% -$26.7K 0.28% 76
2022
Q1
$287K Sell
1,002
-274
-21% -$70.5K 0.26% 80
2021
Q4
$353K Hold
1,276
– – 0.31% 63
2021
Q3
$295K Buy
+1,276
New +$315K 0.28% 77
2021
Q1
$239K Buy
+1,276
New +$250K 0.24% 93

Other funds holding LLY

First Bancorp's LLY Position: Q3 2026 in Review

First Bancorp reduced its Eli Lilly (LLY) stake by 1% in Q3 2026, selling an estimated $3.54K and leaving 287 shares worth $332K. The position accounts for 0.14% of the portfolio, ranked #102.

First Bancorp first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. The position peaked at $472K in Q2 2024. 1,872 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • First Bancorp held 287 shares of Eli Lilly worth $332K as of Q3 2026.
  • First Bancorp sold 3 Eli Lilly shares in Q3 2026, an estimated $3.54K.
  • Eli Lilly made up 0.14% of First Bancorp's portfolio in Q3 2026, its #102 holding.
  • First Bancorp first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • First Bancorp's Eli Lilly position peaked at $472K in Q2 2024.
  • 1,872 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on First Bancorp's 13F filing for Q3 2026, filed 26 Oct 2026.